In this issue of The Journal Chen et al. ( 1 ) report that individuals with insulin resistance (IR) have small, dense LDL. In discussing their finding, I will trace our increasing awareness of Syndrome X (2), within which most investigators would include IR, hypertriglyceridemia (with low levels ofHDL cholesterol), hypertension, and central obesity. I will also discuss the possible etiologies of this common cluster of risk factors for atherosclerotic cardiovascular disease (ASCVD).
What's old? In the early 1960's, Albrink and colleagues described a link between ASCVD, diabetes, and plasma triglyceride levels (TG) (3). In 1967, Reaven et al. (4) reported the link between hypertriglyceridemia, increased levels of plasma insulin, and glucose intolerance. A short time later, they showed that IR was a primary defect in both glucose intolerance and non-insulin-dependent diabetes mellitus (5 his co-workers have found a link between small, dense LDL and specific chromosomal loci, it is very unlikely that a shift in mean LDL diameter is the central abnormality in this syndrome. The two favored etiologic candidates are IR and central obesity. IR as the primary defect would clearly increase an individual's predisposition for non-insulin-dependent diabetes mellitus. It could also result in abnormalities leading to increased plasma fatty acid flux and increased secretion of apoBcontaining lipoproteins by the liver (8) . On the other hand, primary defects in lipogenesis and/or lipolysis in the intraabdominal fat depot could provide increased fatty acids to both drive secretion of apoB-lipoproteins and compete for insulinmediated glucose metabolism (9) . In either case, IR-driven hyperinsulinemia could set the stage for hypertension.
Can a single defect result in the entire cluster ofabnormalities? Although measures of IR appear to be related to glucose, triglyceride, and blood pressure levels in a continuous manner, available data indicate that other genetic predispositions are needed for the appearance of the diseases of Syndrome X; diabetes, dyslipidemia, and hypertension. On the other hand, the risk of ASCVD increases continuously as glucose and blood pressure levels rise, and as HDL levels fall, even in the absence of defined disease states. Thus, we must remember that while patients with Syndrome X may present with only one of its associated diseases, they will very likely have other metabolic abnormalities that, while not meeting the criteria for diseases, will increase their risk for developing ASCVD.
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